{"id":15600,"date":"2025-11-27T11:47:07","date_gmt":"2025-11-27T06:17:07","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=15600"},"modified":"2025-11-27T11:47:07","modified_gmt":"2025-11-27T06:17:07","slug":"stocks-to-buy-today-november-27-2025","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/stocks-to-buy-today-november-27-2025\/","title":{"rendered":"Stocks to Buy Today: November 27, 2025"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

Indian stocks finished higher on Wednesday, supported by broad-based buying in energy, financials and metals. Positive global cues and softer crude oil prices helped the Nifty 50<\/a> close above 26,200 while the Sensex<\/a> moved closer to 85,600, reflecting improved risk appetite.<\/p>\n

Experts note that market sentiment is boosted by expectations of a potential US Fed rate cut, along with steady domestic earnings. If crude prices remain in check and foreign inflows continue, the current upward trend may sustain. Financials and cyclical sectors are expected to remain in focus.<\/p>\n

Against this backdrop, here are the four stocks you may track in today\u2019s trading session.<\/p>\n

<\/span>Nava Ltd [NSE: NAVA]<\/strong><\/span><\/h2>\n

Shares of Nava Ltd<\/a> has come into focus after a promoter group member transferred 14.06 lakh shares internally through a partition deed, a move that does not affect promoter control. The stock is currently near the lower end of its 52-week range, and while near-term momentum is mixed, the company’s long-term return profile remains strong. Investors tracking cyclical power plays may consider Nava for its historical performance while staying mindful of recent earnings softness.<\/p>\n

<\/span>Key Metrics<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Metric<\/strong><\/td>\nValue<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of 26 Nov 2025)<\/td>\n\u20b9527.90<\/td>\n<\/tr>\n
Day Range<\/td>\n\u20b9524.15 – \u20b9534.05<\/td>\n<\/tr>\n
52 Week Range<\/td>\n\u20b9356.05 – \u20b9735.00<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b9146.69 billion<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n16.50<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n1.32%<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n323.33K<\/td>\n<\/tr>\n
Company Type<\/td>\nMidcap Stock<\/a><\/td>\n<\/tr>\n
Beta<\/td>\n1.32<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Shakti Pumps (India) Ltd [NSE: SHAKTIPUMP]<\/strong><\/span><\/h2>\n

Shakti Pumps<\/a> recently touched a new 52-week low and continues to trade below all major moving averages. Despite price pressure, the company has strong long-term growth trends in revenue and profit and maintains a high return on capital. With the stock having corrected sharply, it becomes a potential watchlist candidate for investors seeking high-growth industrial names undergoing a price reset.<\/p>\n

<\/span>Key Metrics<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Metric<\/strong><\/td>\nValue<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of 26 Nov 2025)<\/td>\n\u20b9690.30<\/td>\n<\/tr>\n
Day Range<\/td>\n\u20b9682.80 – \u20b9695.00<\/td>\n<\/tr>\n
52 Week Range<\/td>\n\u20b9670.05 – \u20b91,387.00<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b982.47 billion<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n20.56<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.15%<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n353.81K<\/td>\n<\/tr>\n
Company Type<\/td>\nMidcap<\/td>\n<\/tr>\n
Beta<\/td>\n1.06<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Concord Biotech Ltd [NSE: CONCORDBIO]<\/strong><\/span><\/h2>\n

Concord Biotech<\/a> reported a significant drop in revenue and profit in its latest quarterly results, which has weighed on sentiment. However, the company is expanding through the acquisition of Celliimune Biotech and investing in a solar hybrid project to strengthen operational efficiency. Investors who favour niche biotech players may track Concord as it moves through a phase of earnings consolidation while building new growth avenues.<\/p>\n

<\/span>Key Metrics<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Metric<\/strong><\/td>\nValue<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of 26 Nov 2025)<\/td>\n\u20b91,439.80<\/td>\n<\/tr>\n
Day Range<\/td>\n\u20b91,425.00 – \u20b91,450.40<\/td>\n<\/tr>\n
52 Week Range<\/td>\n\u20b91,345.00 – \u20b92,451.70<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b9149.50 billion<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n46.19<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.75%<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n83.14K<\/td>\n<\/tr>\n
Company Type<\/td>\nMidcap<\/td>\n<\/tr>\n
Beta<\/td>\n0.67<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Dixon Technologies (India) Ltd [NSE: DIXON]<\/strong><\/span><\/h2>\n

Dixon<\/a> recently posted its highest quarterly profit in ten quarters, reflecting strong execution and scalability. Despite this, the stock has corrected this year and is trading in oversold territory. Multiple brokerages remain positive given the company\u2019s backward integration efforts, strong client pipeline and long-term target of reaching \u20b91 trillion in revenue. For investors seeking exposure to India\u2019s electronics manufacturing growth story, Dixon remains an attractive stock to track.<\/p>\n

<\/span>Key Metrics<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Metric<\/strong><\/td>\nValue<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of 26 Nov 2025)<\/td>\n\u20b914,825.00<\/td>\n<\/tr>\n
Day Range<\/td>\n\u20b914,731.00 – \u20b914,890.00<\/td>\n<\/tr>\n
52 Week Range<\/td>\n\u20b912,202.20 – \u20b919,148.90<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b9906.30 billion<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n57.70<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.05%<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n246.02K<\/td>\n<\/tr>\n
Company Type<\/td>\nLargecap Stock<\/a><\/td>\n<\/tr>\n
Beta<\/td>\n1.43<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Conclusion<\/strong><\/span><\/h2>\n

Today\u2019s positive market environment, supported by global cues and stable crude prices, makes it important to track stocks with strong structural growth or meaningful near-term developments. Nava, Shakti Pumps, Concord Biotech and Dixon Technologies each offer distinct opportunities across sectors ranging from power and industrial manufacturing to speciality biotech and electronics sector<\/a>.<\/p>\n

However, stock trading carries risk and requires careful study of fundamentals, chart patterns and broader market conditions. Use tools such as RSI, moving averages, earnings updates and sector trends to guide your decisions and always maintain proper risk management.<\/p>\n

If you’re starting your investment journey, consider opening a Demat account<\/a> with Torus Digital to execute trades efficiently and stay updated with market insights.<\/p>\n

[\/vc_column_text][vc_column_text css=””][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=”share_rating”][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Rate this article<\/h6>\n